Synopsis
The global market for Glabridin was estimated to be worth US$ 34.7 million in 2024 and is forecast to a readjusted size of US$ 59.4 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Glabridin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.
The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.
Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glabridin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glabridin by region & country, by Type, and by Application.
The Glabridin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glabridin.
Market Segmentation
By Company
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Segment by Type
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Segment by Application
Creams and Lotions
Masks
Sunscreen Products
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Glabridin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Glabridin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Glabridin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Index
Available Upon Request